NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?
Qingcai Wang/LinkedIn
Sep 18, 2026, 20:01

Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?

Qingcai Wang, Founder of External Herbal Pouch Therapy for Senior Care, shared on LinkedIn:

“Natural Conception or IVF After 35?

The Real Decision Isn’t Either/Or

Past 35, the question people ask is usually ‘keep trying or start In Vitro Fertilization (IVF)?’

But that’s not actually the decision your clinician makes first.

The real first step is an evaluation – and it doesn’t commit you to anything yet.

The American Society for Reproductive Medicine (ASRM) recommends that evaluation after 6 months of trying at 35 or older, sooner if there’s a known concern, and more immediately past 40.

There’s no universal extra month everyone should spend trying a wellness product before booking that appointment – the evaluation comes first, regardless of what else is on the table.

What that evaluation opens up isn’t a single choice but three possible directions, and each comes with its own question worth asking rather than assuming.

  • If continued trying is still reasonable, ask your clinician what makes waiting appropriate for you specifically, and when to reassess.
  • If medication or insemination comes up, ask which finding it’s meant to address, and what result would change the plan.
  • And if IVF is recommended, ask directly why now – along with the real benefits, burdens, and alternatives, not just the recommendation itself.

One number tends to derail this conversation before it gets anywhere: Anti-Müllerian Hormone (AMH).

It estimates how you might respond to IVF stimulation – not your odds of conceiving naturally, and not your egg quality on its own.

A low result isn’t proof that pregnancy is off the table.

If a number feels alarming, the more useful question isn’t for a new test or product – it’s simply, ‘what does this actually change in my plan?’

Whichever direction the evaluation points, a few things are worth pinning down before any appointment:

  • whether an outcome estimate reflects pregnancy or live birth,
  • and whether it’s per cycle or per transfer;
  • what waiting would actually mean for your specific timeline;
  • the full cost, not just the headline number, including medications, storage, and follow-up;
  • and what the visit schedule looks like, including what support exists if it gets hard.

If you’re also weighing a wellness routine alongside any of this, the honest move is to bring it to your fertility team directly – as part of the same plan, not a separate decision made on the side.

Historical reports on a routine like that can’t be compared to clinic success rates, and they can’t tell you who’s safe to wait longer.

General education. Qingcai Wang, MD, PhD, developed the Five Essences formulations and has a commercial interest in their sale.

Full guide.”

Qingcai Wang, IVF

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.

American Society for Reproductive Medicine AMH anti-Müllerian hormone ASRM Fertility Fertility News IVF OBGYN Qingcai Wang reproductive health Reproductive Medicine Women’s Health
NewsFeed